You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (158)

Journals (0)

1-10 of 158 results for anti-PD-1/PD-L1

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Select article: New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Free access

Letter

First published 2016-4

New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Cheng Chen, Jian-An Huang

European Journal of Inflammation

Select article: Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Open access

Research article

First published 2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Qiaofeng Zhong, Longfeng Zhang, Lin Wu [...]

Therapeutic Advances in Medical Oncology

Select article: The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Open access

Review article

First published 2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Jingjing Qu, Quanhui Mei, Li Liu [...]

Therapeutic Advances in Medical Oncology

Select article: Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Open access

Research article

First published 2022-11

Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Takashi Inoue, Mamoru Narukawa

Cancer Control

Select article: The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review

Open access

Review article

First published 2021-1

The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review

Ke Chen, Xiao Wang, Liu Yang [...]

Cancer Control

Select article: Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

Open access

Research article

First published 2018

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

John Shen, Jason Chang, Melody Mendenhall [...]

Therapeutic Advances in Medical Oncology

Select article: PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research

Open access

Review article

First published 2021

PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research

Yu Zhang, Guang-Ze Mou, Tian-Zhu Li [...]

Technology in Cancer Research & Treatment

Select article: Targeting the Pd-1 Pathway in Renal Cell Carcinoma: A Review

Retricted access

Review article

First published 2017-11

Targeting the Pd-1 Pathway in Renal Cell Carcinoma: A Review

Lisa Derosa, Laurence Albiges, Bernard Escudier

Journal of Onco-Nephrology

Select article: PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway

Open access

Research article

First published 2024-5

PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway

Sixu Zhou, Baogui Wang, Yingying Wei [...]

Cancer Biomarkers

1
2
3
•••
16
10 / page

Article type

Publication date

Subjects

Access